Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/01/20 → 31/12/21 |
Protocol I6T-MC-AMAX A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn’xxs DiseaseVIVID 2. Lilly, Sub-Investigator - Faz 3
- Balaban, Hatice Yasemin (CoI)
Project: Research › OTHER